weight loss drug zepbound news

FDA, Zepbound and obstructive sleep apnea

The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.

CNN on MSN · 5d

FDA approves weight-loss drug Zepbound for obstructive sleep apnea

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.

People on MSN · 15h

Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as tirzepatide, to help people treat obstructive sleep apnea.

Time21d

Which Weight-Loss Drug Is Better: Wegovy or Zepbound?

With more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably ... In March, the U.S. Food and Drug Administration allowed the company to add on Wegovy's label that ...

USA Today24d

Why your co-pay for weight loss drugs like Wegovy just went through the roof

So she asked her doctor about the Eli Lilly drug tirzepatide, which is sold under the brand name Mounjaro to treat diabetes and Zepbound for weight loss. Bonello's workplace insurance plan ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA, Zepbound and obstructive sleep apnea

Trending now